Last reviewed · How we verify
NCT02550496: ETDT
Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis
NA trial testing Dermoscopy in Tinea Capitis in 104 participants. Completed in 23 January 2017.
23 January 2017
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 104 |
| Start date | 4 March 2015 |
| Primary completion | 23 January 2017 |
| Estimated completion | 23 January 2017 |
| Sites | 4 locations across France |
Drugs / interventions tested
- Dermoscopy
Conditions studied
- Tinea Capitis — all drugs for Tinea Capitis →
Sponsor
Centre Hospitalier Universitaire, Amiens
Who can join
Eligibility, any sex, with Tinea Capitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Waiting for a proof by mycological culture is usually necessary before starting a systemic antifungal therapy. It therefore seems to us interesting to evaluate the benefit of using dermoscopy in clinical diagnosis of Tinea Capitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02550496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dermoscopy
Trials testing the same drug.
- NCT07361666 — Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Hea · not yet recruiting
- NCT05321784 — At-Home Dermoscopy Artificial Intelligence · NA · terminated
- NCT04644523 — Dermoscopy in Primary Raynaud's Phenomenon · completed
- NCT03699995 — MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma · NA · terminated
Other recruiting trials for Tinea Capitis
Currently open trials in the same condition.
- NCT06980493 — Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old · Phase 2, PHASE3 · active not recruiting
- NCT07184203 — Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children · NA · recruiting
- NCT07046988 — Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis · recruiting
Other Centre Hospitalier Universitaire, Amiens trials
Trials by the same sponsor.
- NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
- NCT07071662 — Induction of Labor in Breech Presentation · completed
- NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
- NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
- NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02550496 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
- Last refreshed: 10 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02550496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing